FURAZOLIDONE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for furazolidone and what is the scope of patent protection?
Furazolidone
is the generic ingredient in one branded drug marketed by Shire and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for furazolidone.
Summary for FURAZOLIDONE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 2 |
| Drug Master File Entries: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 102 |
| Clinical Trials: | 21 |
| Patent Applications: | 4,092 |
| DailyMed Link: | FURAZOLIDONE at DailyMed |
Recent Clinical Trials for FURAZOLIDONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yongquan Shi | Phase 4 |
| Liaocheng People's Hospital | Phase 1 |
| Shanghai Zhongshan Hospital | N/A |
Medical Subject Heading (MeSH) Categories for FURAZOLIDONE
Anatomical Therapeutic Chemical (ATC) Classes for FURAZOLIDONE
US Patents and Regulatory Information for FURAZOLIDONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shire | FUROXONE | furazolidone | TABLET;ORAL | 011270-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Shire | FUROXONE | furazolidone | SUSPENSION;ORAL | 011323-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
